The number of new highly effective drugs for MS is basically zero in the last 10 years.
SVFC seems to have something of value.
Hirschman needs to get more involved and use his reputation for integrity to get things moving and start to demand accountability with logistic and infrastructure payments. This appears to be a a unique company with a unique, non toxic, holistic, non allergenic therapy with the potential to alleviate great suffering from MS and intractable wounds.
If they can get their act together to even be sold to another big stem cell company, they could be worth a dollar a share. If not, I guess they'll languish at a nickel while another company beats them to a ex vivo procedure, and thousands of debilitated non ambulatory MS patients wait for a contractor to fix up a few lab rooms.
I'm going to gamble that Hirshman doesn't want to look foolish in front of the FDA while mgmt. lollygags. Time to buy more on the way up.